S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Amphastar Pharmaceuticals, Inc.

AMPH XNAS
$19.00 -5.02 (-20.89%) ▼ 15-min delayed
Open
$18.57
High
$19.52
Low
$18.28
Volume
1.98M
Market Cap
$837.77M

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 2.0K Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $171.17M $6.42M $0.14
FY 2025 $719.89M $98.09M $2.10
Q3 2025 $191.84M $17.35M $0.38
Q2 2025 $174.41M $31.03M $0.66

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026
Calendar →

Related Market News

No specific coverage for AMPH yet. Check out our latest market news or earnings calendar.

Get AMPH Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Amphastar Pharmaceuticals, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.